Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes

✍ Scribed by J. Martin Johnston; Sudhakar R. Ihyer; Robin S. Smith; Kuei-Fang Tai; Tara Farmer; Stanley J. Korsmeyer; Nancy L. Nadon; William L. Carroll

• Publisher: John Wiley and Sons
• Year: 1996
• Tongue: English
• Weight: 484 KB
• Volume: 26
• Category: Article
• ISSN: 0014-2980
• DOI: 10.1002/eji.1830260515

✦ Synopsis

Abstract

Somatic hypermutation of immunoglobulin (Ig) genes plays a critical role in the maturation of the human antibody response. The molecular basis of this important process is, however, unknown. To identify cis‐acting sequences that initiate and target hypermutation, we have made three minitransgenes containing different portions of an Ig heavy chain (IgH) locus. Each transgene is a passenger, bearing a nonsense mutation preventing its translation; thus, transgene mutations reflect the endogenous mutational process and are not subject to affinity selection. To study transgenes after their circulation through the compartment associated with hypermutation in vivo, we rescued B cells as hybridomas after hyperimmunizing mice with the hapten 4‐hydroxy‐3‐nitrophenyl acetyl (NP). Hybridoma transgene and endogenous variable regions were amplified by polymerase chain reaction, subcloned, and sequenced. Endogenous anti‐NP VDJ regions show the expected, at times extensive degree of base substitution. In mice bearing the smallest construct, which includes 2.4 kb of 5′ IgH sequences, a rearranged VDJ region, the 5′ matrix attachment region, and the intron enhancer, one of four evaluable hybridomas demonstrates two base substitutions in the V segment of one transgene copy. The two larger constructs include additional 3′ IgH sequences (an α constant region and the 3′ enhancer) and either the original VDJ segment or a substituted T cell receptor β segment. Ten hybridomas derived from mice bearing these larger constructs demonstrate no evidence of targeted mutation, despite demonstrable transgene transcription in all hybridomas. In our system, mutation of a rearranged VDJ segment and surrounding promoter/enhancer regions is not increased by the juxtaposition of a constant region segment and the IgH 3′ enhancer.